Naturally occurring and tumor-associated variants of RNF167 promote lysosomal exocytosis and plasma membrane resealing.

Isoform b Lysosomal exocytosis Mutant Plasma membrane repair RNF167 Tumor Ubiquitin ligase

Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
11 06 2020
Historique:
received: 17 09 2019
accepted: 14 04 2020
pubmed: 16 5 2020
medline: 22 6 2021
entrez: 16 5 2020
Statut: epublish

Résumé

Lysosomal exocytosis and resealing of damaged plasma membrane are essential for cellular homeostasis and tumor invasion. However, very little is known of the molecular machinery that regulates these physiological processes. Moreover, no mutations in any of the known regulators of lysosomal exocytosis in primary tumors of patients have been characterized. Here we demonstrate that RNF167-a, a lysosomal-associated ubiquitin ligase, negatively regulates lysosomal exocytosis by inducing perinuclear clustering of lysosomes. Importantly, we also characterized a set of novel natural mutations in RNF167-a, which are commonly found in diverse tumor types. We found that RNF167-a-K97N mutant, unlike the wild type, localizes in the cytoplasm and does not promote perinuclear lysosomal clustering. Furthermore, cells expressing RNF167-a-K97N exhibit dispersed lysosomes, increased exocytosis and enhanced plasma membrane repair. Interestingly, these functional features of RNF167-a-K97N were shared with a naturally occurring short version of RNF167 (isoform RNF167-b). In brief, the results presented here reveal a novel role of RNF167-a, as well as its natural variants RNF167-a-K97N and RNF167-b, as an upstream regulator of lysosomal exocytosis and plasma membrane resealing.

Identifiants

pubmed: 32409562
pii: jcs.239335
doi: 10.1242/jcs.239335
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Auteurs

Sreeja V Nair (SV)

School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Thiruvananthapuram 695551, Kerala, India.

Nikhil Dev Narendradev (ND)

School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Thiruvananthapuram 695551, Kerala, India.

Rithwik P Nambiar (RP)

School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Thiruvananthapuram 695551, Kerala, India.

Rakesh Kumar (R)

Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India.

Srinivasa M Srinivasula (SM)

School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Thiruvananthapuram 695551, Kerala, India sms@iisertvm.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH